Kenneth J Olivier Jr
Overview
Explore the profile of Kenneth J Olivier Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferretti A, Kula T, Wang Y, Nguyen D, Weinheimer A, Dunlap G, et al.
Immunity
. 2020 Oct;
53(5):1095-1107.e3.
PMID: 33128877
Developing effective strategies to prevent or treat coronavirus disease 2019 (COVID-19) requires understanding the natural immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used an unbiased, genome-wide...
2.
Fitzgerald J, Johnson B, Baum J, Adams S, Iadevaia S, Tang J, et al.
Mol Cancer Ther
. 2013 Nov;
13(2):410-25.
PMID: 24282274
Although inhibition of the insulin-like growth factor (IGF) signaling pathway was expected to eliminate a key resistance mechanism for EGF receptor (EGFR)-driven cancers, the effectiveness of IGF-I receptor (IGF-IR) inhibitors...
3.
Reynolds J, Geretti E, Hendriks B, Lee H, Leonard S, Klinz S, et al.
Toxicol Appl Pharmacol
. 2012 Jun;
262(1):1-10.
PMID: 22676972
Anthracycline-based regimens are a mainstay of early breast cancer therapy, however their use is limited by cardiac toxicity. The potential for cardiotoxicity is a major consideration in the design and...
4.
Olivier Jr K, Price K, Hutto D, Lerche N, Mansfield K, Simmons J, et al.
J Immunotoxicol
. 2010 May;
7(2):138-46.
PMID: 20441554
Non-human primates (NHP) are used to best understand and address pharmacology and toxicology obligations for human patients with highest and/or unmet need. In order to ensure the most appropriate care...